4.5 Article

Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors

期刊

ARCHIV DER PHARMAZIE
卷 -, 期 -, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/ardp.202300201

关键词

Alzheimer's disease; anticholinesterase; benzimidazole; molecular docking; thiazole

向作者/读者索取更多资源

This study designed and synthesized benzimidazole-thiazole hybrids as potential inhibitors for the treatment of Alzheimer's disease, showing dual inhibitory effects against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Compound 4d demonstrated significant neuroprotective effects and may serve as a template for developing more potent inhibitors in the future.
Dementia is a cognitive disturbance that is generally correlated with central nervous system diseases, especially Alzheimer's disease. The limited number of medications available is insufficient to improve the lifestyle of the patients suffering from this disease. Thus, new benzimidazole-thiazole hybrids (3-10) were designed and synthesized as acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory agents. The in vitro evaluation displayed that the derivatives 4b, 4d, 5b, 6a, 7a, and 8b demonstrated dual inhibitory efficiency against both AChE with IC50 ranging from 4.55 to 8.62 mu M and BChE with IC50 ranging from 3.50 to 8.32 mu M. By analyzing the Lineweaver-Burk plot, an uncompetitive form of inhibition was determined for the highly active compound 4d, revealing its inhibition type. The human telomerase reverse transcriptase-immortalized retinal pigment epithelial cell line was used to ensure the safety of the most potent cholinesterase inhibitors. Furthermore, compounds 4b, 4d, 5b, 6a, 7a, and 8b were evaluated for their neuroprotective and antioxidant properties, as well as their ability to suppress COX-2. The results demonstrated that compounds 4d, 5b, and 8b presented significant neuroprotection efficiency against H2O2-induced damage in SH-SY5Y cells with % cell viability of 67.42 +/- 7.90%, 62.51 +/- 6.71%, and 72.61 +/- 8.10%, respectively, while the tested candidates did not reveal significant antioxidant activity. Otherwise, compounds 4b, 6a, 7a, and 8b displayed outstanding COX-2 inhibition effects with IC50 ranging from 0.050 to 0.080 mu M relative to celecoxib (IC50 = 0.050 mu M). In addition, molecular docking was carried out for the potent benzimidazole-thiazole hybrids with the active sites of both AChE (PDB ID: 4EY7) and BChE (PDB code: 1P0P). The tested candidates fit well in the active sites of both portions, with docking scores ranging from -8.65 to -6.64 kcal/mol (for AChE) and -8.71 to -7.73 kcal/mol (for BChE). In silico results show that the synthesized benzimidazole-thiazole hybrids have good physicochemical and pharmacokinetic properties with no Lipinski rule violations. The preceding results exhibited that compound 4d could be used as a new template for developing more significant cholinesterase inhibitors in the future.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据